Use of COMBINATION ANTIRETROVIRAL THERAPY In Pregnant Women With HIV Disease
Important advances in human immunodeficiency virus (HIV) medicine have brought about numerous changes in the clinical care of HIV-infected individuals. The availability of protease inhibitors to treat HIV infection, the introduction of HIV-RNA polymerase chain reaction viral load tests to monitor re...
Gespeichert in:
| Veröffentlicht in: | MCN, the American journal of maternal child nursing the American journal of maternal child nursing, 1998-11, Vol.23 (6), p.307-312 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 312 |
|---|---|
| container_issue | 6 |
| container_start_page | 307 |
| container_title | MCN, the American journal of maternal child nursing |
| container_volume | 23 |
| creator | Newshan, Gayle Hoyt, Mary Jo |
| description | Important advances in human immunodeficiency virus (HIV) medicine have brought about numerous changes in the clinical care of HIV-infected individuals. The availability of protease inhibitors to treat HIV infection, the introduction of HIV-RNA polymerase chain reaction viral load tests to monitor responses to therapy, and the greater clinical benefit offered by combination highly active antiretroviral therapy (HAART) over monotherapy have dramatically decreased morbidity and mortality rates. The safety and efficacy of HAART has not been proved in pregnant women with HIV, although withholding HAART in HIV-infected women because of pregnancy is not recommended. This article presents an overview of important clinical issues relevant to the use of combination antiretroviral therapy in pregnancy. |
| doi_str_mv | 10.1097/00005721-199811000-00006 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_764056968</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70066804</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2346-948d99e30ef1c9efeff0e0898f6b108134b2bf2390e6326ae122032ce5db140f3</originalsourceid><addsrcrecordid>eNp9kU1PwkAQhjdGg4j-BJM96am6H-3SPVZEaVIpaQroadOWWUH7gd0S4r-3CHrTuUxm5n1nkmcQwpTcUCL7t6QNp8-oRaV0KW0ra9cSR6hLHS4tIlx-jLqEC2pJJp9P0ZkxbzuJ5KKDOq1JOox1UTA1gCuNB-HTnT_2Yj8cY28c-9EwjsKZH3kBjkfDyJu8YL_Ekxpey6Rs8LwqoMTzVbPEI3-G71cGEgPn6EQnuYGLQ-6h6cMwHoysIHz0B15gZYzbwpK2u5ASOAFNMwkatCZAXOlqkVLiUm6nLNWMSwKCM5EAZYxwloGzSKlNNO-h6_3edV19bMA0qliZDPI8KaHaGNUXNnGEbBn00NX_ypaZcIndCt29MKsrY2rQal2viqT-VJSoHXL1g1z9Iv9uidZ6ebixSQtY_BoPjNu5vZ9vq7yB2rznmy3UaglJ3izVX5_kX88AhpQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70066804</pqid></control><display><type>article</type><title>Use of COMBINATION ANTIRETROVIRAL THERAPY In Pregnant Women With HIV Disease</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Newshan, Gayle ; Hoyt, Mary Jo</creator><creatorcontrib>Newshan, Gayle ; Hoyt, Mary Jo</creatorcontrib><description>Important advances in human immunodeficiency virus (HIV) medicine have brought about numerous changes in the clinical care of HIV-infected individuals. The availability of protease inhibitors to treat HIV infection, the introduction of HIV-RNA polymerase chain reaction viral load tests to monitor responses to therapy, and the greater clinical benefit offered by combination highly active antiretroviral therapy (HAART) over monotherapy have dramatically decreased morbidity and mortality rates. The safety and efficacy of HAART has not been proved in pregnant women with HIV, although withholding HAART in HIV-infected women because of pregnancy is not recommended. This article presents an overview of important clinical issues relevant to the use of combination antiretroviral therapy in pregnancy.</description><identifier>ISSN: 0361-929X</identifier><identifier>EISSN: 1539-0683</identifier><identifier>DOI: 10.1097/00005721-199811000-00006</identifier><identifier>PMID: 9819522</identifier><language>eng</language><publisher>United States: Lippincott Williams & Wilkins, Inc</publisher><subject>Adult ; AIDS/HIV ; Anti-HIV Agents - therapeutic use ; Drug Therapy, Combination ; Female ; HIV Infections - drug therapy ; HIV Protease Inhibitors - therapeutic use ; Humans ; Infectious Disease Transmission, Vertical - prevention & control ; Nursing ; Pregnancy ; Pregnancy Complications, Infectious - drug therapy ; Pregnancy Complications, Infectious - virology</subject><ispartof>MCN, the American journal of maternal child nursing, 1998-11, Vol.23 (6), p.307-312</ispartof><rights>1998 Lippincott Williams & Wilkins, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2346-948d99e30ef1c9efeff0e0898f6b108134b2bf2390e6326ae122032ce5db140f3</citedby><cites>FETCH-LOGICAL-c2346-948d99e30ef1c9efeff0e0898f6b108134b2bf2390e6326ae122032ce5db140f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9819522$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Newshan, Gayle</creatorcontrib><creatorcontrib>Hoyt, Mary Jo</creatorcontrib><title>Use of COMBINATION ANTIRETROVIRAL THERAPY In Pregnant Women With HIV Disease</title><title>MCN, the American journal of maternal child nursing</title><addtitle>MCN Am J Matern Child Nurs</addtitle><description>Important advances in human immunodeficiency virus (HIV) medicine have brought about numerous changes in the clinical care of HIV-infected individuals. The availability of protease inhibitors to treat HIV infection, the introduction of HIV-RNA polymerase chain reaction viral load tests to monitor responses to therapy, and the greater clinical benefit offered by combination highly active antiretroviral therapy (HAART) over monotherapy have dramatically decreased morbidity and mortality rates. The safety and efficacy of HAART has not been proved in pregnant women with HIV, although withholding HAART in HIV-infected women because of pregnancy is not recommended. This article presents an overview of important clinical issues relevant to the use of combination antiretroviral therapy in pregnancy.</description><subject>Adult</subject><subject>AIDS/HIV</subject><subject>Anti-HIV Agents - therapeutic use</subject><subject>Drug Therapy, Combination</subject><subject>Female</subject><subject>HIV Infections - drug therapy</subject><subject>HIV Protease Inhibitors - therapeutic use</subject><subject>Humans</subject><subject>Infectious Disease Transmission, Vertical - prevention & control</subject><subject>Nursing</subject><subject>Pregnancy</subject><subject>Pregnancy Complications, Infectious - drug therapy</subject><subject>Pregnancy Complications, Infectious - virology</subject><issn>0361-929X</issn><issn>1539-0683</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU1PwkAQhjdGg4j-BJM96am6H-3SPVZEaVIpaQroadOWWUH7gd0S4r-3CHrTuUxm5n1nkmcQwpTcUCL7t6QNp8-oRaV0KW0ra9cSR6hLHS4tIlx-jLqEC2pJJp9P0ZkxbzuJ5KKDOq1JOox1UTA1gCuNB-HTnT_2Yj8cY28c-9EwjsKZH3kBjkfDyJu8YL_Ekxpey6Rs8LwqoMTzVbPEI3-G71cGEgPn6EQnuYGLQ-6h6cMwHoysIHz0B15gZYzbwpK2u5ASOAFNMwkatCZAXOlqkVLiUm6nLNWMSwKCM5EAZYxwloGzSKlNNO-h6_3edV19bMA0qliZDPI8KaHaGNUXNnGEbBn00NX_ypaZcIndCt29MKsrY2rQal2viqT-VJSoHXL1g1z9Iv9uidZ6ebixSQtY_BoPjNu5vZ9vq7yB2rznmy3UaglJ3izVX5_kX88AhpQ</recordid><startdate>199811</startdate><enddate>199811</enddate><creator>Newshan, Gayle</creator><creator>Hoyt, Mary Jo</creator><general>Lippincott Williams & Wilkins, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>ASE</scope><scope>FPQ</scope><scope>K6X</scope></search><sort><creationdate>199811</creationdate><title>Use of COMBINATION ANTIRETROVIRAL THERAPY In Pregnant Women With HIV Disease</title><author>Newshan, Gayle ; Hoyt, Mary Jo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2346-948d99e30ef1c9efeff0e0898f6b108134b2bf2390e6326ae122032ce5db140f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Adult</topic><topic>AIDS/HIV</topic><topic>Anti-HIV Agents - therapeutic use</topic><topic>Drug Therapy, Combination</topic><topic>Female</topic><topic>HIV Infections - drug therapy</topic><topic>HIV Protease Inhibitors - therapeutic use</topic><topic>Humans</topic><topic>Infectious Disease Transmission, Vertical - prevention & control</topic><topic>Nursing</topic><topic>Pregnancy</topic><topic>Pregnancy Complications, Infectious - drug therapy</topic><topic>Pregnancy Complications, Infectious - virology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Newshan, Gayle</creatorcontrib><creatorcontrib>Hoyt, Mary Jo</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>British Nursing Index</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>British Nursing Index</collection><jtitle>MCN, the American journal of maternal child nursing</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Newshan, Gayle</au><au>Hoyt, Mary Jo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Use of COMBINATION ANTIRETROVIRAL THERAPY In Pregnant Women With HIV Disease</atitle><jtitle>MCN, the American journal of maternal child nursing</jtitle><addtitle>MCN Am J Matern Child Nurs</addtitle><date>1998-11</date><risdate>1998</risdate><volume>23</volume><issue>6</issue><spage>307</spage><epage>312</epage><pages>307-312</pages><issn>0361-929X</issn><eissn>1539-0683</eissn><abstract>Important advances in human immunodeficiency virus (HIV) medicine have brought about numerous changes in the clinical care of HIV-infected individuals. The availability of protease inhibitors to treat HIV infection, the introduction of HIV-RNA polymerase chain reaction viral load tests to monitor responses to therapy, and the greater clinical benefit offered by combination highly active antiretroviral therapy (HAART) over monotherapy have dramatically decreased morbidity and mortality rates. The safety and efficacy of HAART has not been proved in pregnant women with HIV, although withholding HAART in HIV-infected women because of pregnancy is not recommended. This article presents an overview of important clinical issues relevant to the use of combination antiretroviral therapy in pregnancy.</abstract><cop>United States</cop><pub>Lippincott Williams & Wilkins, Inc</pub><pmid>9819522</pmid><doi>10.1097/00005721-199811000-00006</doi><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0361-929X |
| ispartof | MCN, the American journal of maternal child nursing, 1998-11, Vol.23 (6), p.307-312 |
| issn | 0361-929X 1539-0683 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_764056968 |
| source | MEDLINE; Journals@Ovid Complete |
| subjects | Adult AIDS/HIV Anti-HIV Agents - therapeutic use Drug Therapy, Combination Female HIV Infections - drug therapy HIV Protease Inhibitors - therapeutic use Humans Infectious Disease Transmission, Vertical - prevention & control Nursing Pregnancy Pregnancy Complications, Infectious - drug therapy Pregnancy Complications, Infectious - virology |
| title | Use of COMBINATION ANTIRETROVIRAL THERAPY In Pregnant Women With HIV Disease |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T17%3A22%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Use%20of%20COMBINATION%20ANTIRETROVIRAL%20THERAPY%20In%20Pregnant%20Women%20With%20HIV%20Disease&rft.jtitle=MCN,%20the%20American%20journal%20of%20maternal%20child%20nursing&rft.au=Newshan,%20Gayle&rft.date=1998-11&rft.volume=23&rft.issue=6&rft.spage=307&rft.epage=312&rft.pages=307-312&rft.issn=0361-929X&rft.eissn=1539-0683&rft_id=info:doi/10.1097/00005721-199811000-00006&rft_dat=%3Cproquest_cross%3E70066804%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70066804&rft_id=info:pmid/9819522&rfr_iscdi=true |